No Detail Found!

Anticonvulsive Activity of Duloxetine: a New Choice for the Epileptic Patients with Depression.

Author(s)
Yi Wu Medical College, Jinggangshan University, Ji'an, Jiangxi, China
Yuping Huang Department of Biochemistry and Molecular Biology; Gannan Medical College;, Ganzhou, China
Mingxia Song Medical College, Jinggangshan University, Ji'an, Jiangxi, China
Zongping Zhang Medical College, Jinggangshan University, Ji'an, Jiangxi, China
Zhen Liang Medical College, Jinggangshan University, Ji'an, Jiangxi, China
Xianqing Deng Medical College, Jinggangshan University, Ji'an, Jiangxi, China
Abstract
The aim of this study was to investigate the antiepileptic effects of duloxetine in the maximal electroshock test and convulsions induced by four compounds: Pentylenetetrazole, 3-mercaptopropionic acid, thiosemicarbazide, and bicuculline. Duloxetine exhibited moderate anticonvulsive activity with an ED50 (median effective dose) of 48.21 mg/kg in the maximal electroshock test in mice. The anticonvulsive action of duloxetine was also confirmed in chemicalinduced seizure tests, where this drug decreased tonic convulsions. Single administration of duloxetine (6.25-25 mg/kg) significantly increased the anticonvulsant effects of valproate, carbamazepine, and oxcarbazepine in the maximal electroshock test. Furthermore, pretreatment with thiosemicarbazide (an inhibitor of GABA synthesis enzyme) significantly increased the ED50 of duloxetine, suggesting the GABAergic system may contribute to the anticonvulsive action of duloxetine. These results support the use of duloxetine in the treatment of coexisting depression and epilepsy.
Publication Details
Page(s) 997-1003
DOI DOI not available
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 32, Issue: 3, Year: 2019

Request the full text from PASTIC

Keywords
electroshock maximal
0

Citations

0

Downloads

91

Views